Cargando…
Suicide genes: monitoring cells in patients with a safety switch
Clinical trials increasingly incorporate suicide genes either as direct lytic agents for tumors or as safety switches in therapies based on genetically modified cells. Suicide genes can also be used as non-invasive reporters to monitor the biological consequences of administering genetically modifie...
Autores principales: | Eissenberg, Linda G., Rettig, Michael, Dehdashti, Farrokh, Piwnica-Worms, David, DiPersio, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222135/ https://www.ncbi.nlm.nih.gov/pubmed/25414668 http://dx.doi.org/10.3389/fphar.2014.00241 |
Ejemplares similares
-
Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020) -
Mobilized peripheral blood: an updated perspective
por: Karpova, Darja, et al.
Publicado: (2019) -
Innovations in hematopoietic stem-cell mobilization: a review of the
novel CXCR4 inhibitor motixafortide
por: Crees, Zachary D., et al.
Publicado: (2023) -
First-in-Humans Evaluation of Safety and Dosimetry of (64)Cu-LLP2A for PET Imaging
por: Laforest, Richard, et al.
Publicado: (2023) -
The inducible caspase-9 suicide gene system as a “safety switch” to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
por: Gargett, Tessa, et al.
Publicado: (2014)